Evaluation of the Efficacy of M+Pac® in One- and Two-Dose Regimens Against Competitor One-Dose Mycoplasma Hyopneumoniae Bacterins

Groth, DougRapp-Gabrielson, VickiSaltzman, Ryan2013-11-262013-11-262001-09-15https://hdl.handle.net/11299/160655en-USswinepigherd healthEvaluation of the Efficacy of M+Pac® in One- and Two-Dose Regimens Against Competitor One-Dose Mycoplasma Hyopneumoniae BacterinsConference Paper